Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Kilitch Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524500 P/E (TTM) :20.03
ISIN Demat:INE729D01010 Div & Yield %:0 EPS (TTM) :18.25
Book Value (RS) :173.2581804 Market Cap (Rs Cr.):638.92 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.170.130.110.100.09
Long Term Debt-Equity Ratio0.060.000.000.000.00
Current Ratio1.491.431.171.021.20
Fixed Assets4.243.373.183.302.54
Inventory18.8243.6533.4624.4815.30
Debtors2.502.292.493.273.51
Interest Cover Ratio15.2412.5617.9118.418.17
PBIDTM (%)21.1020.2318.6314.9211.90
PBITM (%)20.1419.2917.4914.0110.27
PBDTM (%)19.7818.6917.6514.1610.64
CPM (%)15.4014.2914.4810.939.08
APATM (%)14.4413.3513.3510.017.46
ROCE (%)13.1410.749.897.824.20
RONW (%)11.028.398.416.183.32

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)